01 October 2007 15:11 [Source: ICIS news]
LONDON (ICIS news)--INEOS NOVA’s joint venture has just been expanded to include NOVA’s STYRENIX unit and other styrenic polymer assets and is expected to post $3.8bn in revenues per annum, the two companies said on Monday.
The expanded joint venture between INEOS and NOVA, which was announced in March, was set to generate earnings from manufacturing sites in the US, Canada, France, Germany, the Netherlands and Sweden, said INEOS NOVA, which is headquartered in Illinois.
Dylark polymers will not be included in the joint venture and would continue to be manufactured and sold by NOVA Chemicals, said the company.
Prior to the joint venture, Alberta-based NOVA had been planning for some time to either sell STYRENIX or find a joint-venture solution for it.
INEOS is a UK-based chemicals company.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|